Nuron Biotech, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.nuronbiotech.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers
Phase 2
- Conditions
- Infectious Disease
- First Posted Date
- 2012-11-22
- Last Posted Date
- 2013-09-23
- Lead Sponsor
- Nuron Biotech Inc.
- Target Recruit Count
- 220
- Registration Number
- NCT01732198
Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Phase 3
- Conditions
- Relapsing Remitting Multiple Sclerosis
- First Posted Date
- 2011-11-04
- Last Posted Date
- 2013-09-23
- Lead Sponsor
- Nuron Biotech Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT01464905
News
No news found